INVIZYNE
Live / Applied — Statement of use — non-final action mailed (as of 18 Mar 2026)
What this means for you
Not registered yet, but its 29 Oct 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90287671
- Mark type
- Design + words
- Filed
- 29 Oct 2020
- Published for opposition
- 04 Jan 2022
- Attorney of record
- Thomas C. Lundin Jr.
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Fragrances; terpenes for use in essential oils
- Class 004 — Lubricants and fuels: Biofuels; fuels, biofuels and biodiesels based on energy-producing organic compounds, namely, terpenes, isoprenoids, alcohols, fatty acids, esters, alkanes, and alkenes
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, alcohols, esters, alkaloids, polyketides, steroids, isoprenoids, and non-ribosomal peptides, for use the treatment of pain, neuropathic pain, cancer pain, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, multiple sclerosis, spinal cord injury, bladder disfunction, peripheral neuropathy, spasticity, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, post-traumatic stress disorder, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse, epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome, chromosome disorders, and metabolic disorders; anti-inflammatories; analgesics; nutraceuticals for use as a dietary supplement; dietary and nutritional supplements; none of the foregoing containing CBD, cannabinoids or tryptamines
- Class 030 — Staple foods: Flavor enhancers for use in food and beverage products
Owner
- Invizyne Technologies, Inc., Monrovia, CA, US
- Invizyne Technologies, Inc., Monrovia, CA, US
Prosecution history
- 18 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 16 Jan 2024 — ASSIGNED TO EXAMINER
- 29 Sept 2023 — ASSIGNED TO EXAMINER
- 05 Sept 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Aug 2023 — USE AMENDMENT FILED
- 31 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Aug 2023 — TEAS STATEMENT OF USE RECEIVED
- 23 Aug 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 23 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED